Obesity Patient Journey Survey

Obesity Patient Journey Survey The Gastrointestinal Society and the Canadian Society of Intestinal Research represent patients on a variety of healthcare fronts. Obesity is a chronic disease defined by an excessive amount of body fat that might put an individual at risk of increased health complications. Managing this disease can be challenging and multi-faceted. This [...]

By |2024-01-22T10:26:00-08:00August 16, 2023|News, Surveys|

Clinical Trials Survey Results

Clinical Trials Survey Results Clinical trials are a vital step in the development of new treatments, and they contribute to well-balanced, effective healthcare. Without clinical trials, we would never be able to adequately test new treatments, including medicines, supplements, devices, dietary modifications, behavioural and psychological therapies, various procedures, and more. No testing means no new [...]

By |2023-03-14T14:58:24-07:00March 14, 2023|News, Surveys|

Clinical Trials Survey

Clinical Trials Survey Clinical trials are a key aspect of the development process for new medications, devices, or procedures. Researchers test these on volunteers to determine whether a specific treatment is safe and effective for a disease or disorder. Clinical trial design can take different approaches that are complex. We’re checking in to see [...]

By |2023-01-24T21:31:30-08:00October 4, 2022|News, Surveys|

Gaps in Healthcare Survey

Gaps in Healthcare Survey We designed this survey to understand your opinions and outlook regarding current access to medicines in various healthcare settings (e.g., local pharmacy, hospital) and advocate for system-wide improvements in care and treatment. We will use this information anonymously and in aggregate to shape future programming and to inform community members, healthcare [...]

By |2022-07-27T11:29:59-07:00July 27, 2022|News, Surveys|

Poop Anxiety Survey Results

Poop Anxiety Survey Results Everybody poops, it’s a daily occurrence for much of the population. Yet, so many people experience shame and anxiety around the process. While most of us have no problem using public washrooms to urinate, having a bowel movement in a public toilet can cause a ton of stress. This is known [...]

By |2022-03-15T16:19:27-07:00March 15, 2022|News, Surveys|

IBD Patient Journey Survey

IBD Patient Journey Survey Are you living with an inflammatory bowel disease (IBD)? Take this survey to let us know your opinions and outlook on living with and managing this chronic disease. This survey is open to Canadians who have received a diagnosis for IBD (Crohn’s disease, ulcerative colitis, ulcerative proctitis, microscopic colitis, and indeterminate [...]

By |2022-07-27T10:46:32-07:00January 28, 2022|News, Surveys|

Survey Report: Biosimilars in Alberta and BC

Survey Report: Biosimilars in Alberta and BC Four provinces across Canada have implemented non-medical switching (NMS) policies for biologic medications. In these jurisdictions, to maintain public coverage, individuals must switch from their originator biologic to a corresponding biosimilar. In May 2019, the government of British Columbia (BC) launched their NMS policy and Alberta followed shortly [...]

By |2021-11-11T10:15:24-08:00December 20, 2021|News, Past Newsletter Articles, Surveys|

Bone Health Survey Results

Bone Health Survey Results Bone is living tissue. Our bodies continually remove or resorb old bone and form new bone. Strong bone is a result of both the density and quality of bone. Healthy bone development involves the intake of nutrients, such as calcium, vitamin D, and phosphorus, along with mechanical force via weight-bearing exercise. [...]

By |2021-11-11T09:51:31-08:00December 20, 2021|News, Past Newsletter Articles, Surveys|

Biosimilars Patient Survey – AB and BC

Biosimilars Survey 2021 The Gastrointestinal Society represents Canadian patients on a variety of healthcare fronts, including access to medications. We have designed this survey to help us understand your opinions and outlook regarding switching from originator biologics to their biosimilars. We will use this information anonymously and in aggregate to shape future programming and to [...]

By |2021-08-31T15:05:16-07:00August 31, 2021|News, Surveys|
Go to Top